• All
  • Primary Antibodies
  • Conjugated Antibodies for IF
  • Conjugated Antibodies for FC
  • Secondary Antibodies
  • Antibody Labeling KitsNew
  • ELISA Kits
  • IHC Kits
  • Magnetic Cell Separation Kits
  • Cytokines & Growth Factors
  • Neutralizing/activating Antibodies
  • Nanobody-based Reagents
  • Accessory Products and Kits
  • Fusion Proteins
×
×
Host
0
Species Reactivity
0
Species Reactivity
0
Conjugate
0
Conjugate
0
Compatible Species
0
Conjugate
0
Filter:
  • Western Blot (WB) analysis of various lysates using ARHGEF39 Polyclonal antibody (21182-1-AP)

    WB analysis using 21182-1-AP (same clone as 21182-1-PBS)

    Various lysates were subjected to SDS PAGE followed by western blot with 21182-1-AP (ARHGEF39 antibody) at dilution of 1:4000 incubated at room temperature for 1.5 hours. This data was developed using the same antibody clone with 21182-1-PBS in a different storage buffer formulation.

This product is currently not available for sale.

Product Information

21182-1-PBS targets ARHGEF39 in WB, Indirect ELISA applications and shows reactivity with human samples.

Tested Reactivity human
Host / Isotype Rabbit / IgG
Class Polyclonal
Type Antibody
Immunogen ARHGEF39 fusion protein Ag15473 Predict reactive species
Full Name chromosome 9 open reading frame 100
Calculated Molecular Weight 335 aa, 38 kDa
Observed Molecular Weight34 kDa
GenBank Accession NumberBC033666
Gene Symbol C9orf100
Gene ID (NCBI) 84904
Conjugate Unconjugated
Form Liquid
Purification MethodAntigen affinity purification
UNIPROT IDQ8N4T4
Storage Buffer PBS only, pH 7.3.
Storage ConditionsStore at -80°C.

Background Information

Rho guanine nucleotide exchange factor 39 (ARHGEF39), also called C9orf100, is part of the family of Rho guanine nucleotide exchange factors (RhoGEFs) that activate small Rho GTPases to regulate a wide variety of cellular processes. ARHGEF39 was previously implicated in developmental language disorder (DLD) via a functional polymorphism that can disrupt post-transcriptional regulation by microRNAs.